Zoster Eye Disease Study: A multi-center, randomized, double-masked, placebo-controlled clinical trial of suppresive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment. | Dartmouth-Hitchcock
Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
Zoster Eye Disease Study: A multi-center, randomized, double-masked, placebo-controlled clinical trial of suppresive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.
Principal Investigator (?)
Study Number
SF17108
Summary
This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment. 
Phase (?)
Phase III
Sponsor (?)
Contact

Christine Toutain-Kidd

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0